Irish Mirror on MSN

Red flag sign of dementia could be spotted in your driving habits, according to new study

A new study has found that changes in driving patterns could signal cognitive decline, with researchers identifying specific ...

Red flag signs of dementia could be spotted when you drive - new study

A red flag warning sign of dementia could appear when driving, according to a new study. Research has found that certain ...

Red flag signs of dementia could appear when driving - new study says

A new study has suggested that changes in driving habits could be an early warning sign of dementia. The research indicates ...
The Healthy @Reader's Digest on MSN

Over 40? Here are 9 clever memory exercises to start doing today

Yes, some of these are fun! Here are neurology and brain scientists' tips to "exercise" this super organ—your brilliant brain ...
TMCnet

Biologics License Application for Subcutaneous Formulation of "LEQEMBI®" (lecanemab) for the Treatment of Early Alzheimer's Disease Accepted in China

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...
Daily Express US on MSN

New study finds these driving habits could signal red flag sign of dementia

A new study published in Neurology journal has identified specific changes in driving behavior that may indicate mild ...
Le Lézard

BLA for subcutaneous formulation of Leqembi® accepted in China

BioArctic AB's (publ) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of Leqembi (lecanemab) for ...

BioArctic: BLA for subcutaneous formulation of Leqembi accepted in China

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation ...
JCN Newswire

Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Accepted in China

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

‘Whose Line Is It Anyway?’ Star Colin Mochrie Has Medical Emergency, Cancels Tour Dates

Colin Mochrie canceled several of his comedy tour dates amid a medical emergency: a detached retina. On Friday, January 2, ...

‘Whose Line Is It Anyway?’ star Colin Mochrie, 68, suffers ‘medical situation,’ undergoing emergency surgery

“Whose Line Is It Anyway?” star Colin Mochrie is undergoing emergency surgery for a serious eye condition, forcing him to ...